
Water analytics and treatment company Veralto (NYSE:VLTO) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 3.8% year on year to $1.40 billion. Its non-GAAP profit of $1.04 per share was 6% above analysts’ consensus estimates.
Is now the time to buy VLTO? Find out in our full research report (it’s free for active Edge members).
Veralto’s fourth quarter results were met with a negative market reaction, as the company’s revenue came in slightly below Wall Street expectations despite year-on-year growth. Management attributed the shortfall largely to lower volumes caused by three fewer shipping days, as well as macroeconomic headwinds that affected industrial and municipal demand. CEO Jennifer Honeycutt highlighted the resilience of the company’s recurring revenue streams, which make up 60% of sales, and noted that operational flexibility—such as regionalizing production lines—helped offset tariff pressures and supply chain disruptions. CFO Sameer Ralhan underscored that pricing actions were the key driver of core sales growth for the quarter, while underlying demand remained steady across both Water Quality and PQI segments.
Looking ahead, Veralto’s guidance for 2026 reflects a cautious stance, with management pointing to continued macroeconomic uncertainty and integration costs from recent acquisitions, particularly In-Situ. While the company expects mid- to high single-digit adjusted EPS growth, Ralhan emphasized that pricing will remain a significant lever, supplemented by efficiency gains and the gradual easing of tariff-related headwinds. Honeycutt stated, “Our durable business model and strong secular growth drivers position us for another year of steady core sales growth.” However, management acknowledged that earnings growth will be more modest than in previous years, with some dilution from acquisition-related costs and a prudent approach to cost management.
Management identified pricing actions, recurring revenue strength, and recent portfolio moves as the primary forces shaping Q4 performance and the 2026 outlook.
Veralto’s outlook for 2026 is shaped by pricing discipline, operational improvements, and integrating recent acquisitions amid ongoing macroeconomic uncertainty.
Going forward, the StockStory team will be watching (1) the pace and effectiveness of In-Situ integration and its contribution to revenue growth, (2) sustained pricing discipline and its impact on both top-line and margins, and (3) progress in expanding recurring revenues and service contracts, particularly in newly targeted geographies and verticals. New product adoption and further portfolio optimization will also be important markers.
Veralto currently trades at $90.67, down from $97.41 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| Aug-19 | |
| Jul-29 | |
| Jul-29 | |
| Jul-28 | |
| Jul-28 | |
| Jul-21 | |
| Jul-13 | |
| Jun-12 | |
| Jun-08 | |
| Jun-04 | |
| May-27 | |
| May-14 | |
| Apr-30 | |
| Apr-29 | |
| Apr-28 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite